Tag: SMAR

CURR Report, Options Ideas

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

Many of our regular readers will be familiar with CURE Pharmaceutical, a company that we profiled in a recent premarket report on November 25th. That morning, CURR shares registered a low of .99, and have made a pretty impressive move in the eight trading sessions since. Yesterday brought a new high of 1.82, which marks an overall increase of 83%

When we initially mentioned it, we looked at CURR as a possible bottom-play, which it certainly turned out to be. We would now classify it as a momentum mover, although as we’ve mentioned previously, there is an interesting backstory as well. 

In our first report, we commented on the interesting proprietary technology the company had for vitamin/supplement delivery via orally-ingested film strips called Nutri-Strips. According to a recent statement from CURE CSO Nancy Duitch (CEO of The Sera Labs) the recent acquisition of The Sera Labs by CURE was primarily about assisting with and expediting the commercialization of Sera’s products that utilize this technology, which is referred to as RAD3 (Rapid Activation Delivery).

The first variety of oral supplements that CURE has made available via its online retail portal is a sleep aid, and according to the company, consumers can expect between three and six others to hit the storefront in early 2021.

The roll-out and advertising campaigns designed by CURE for the emerging lines have been described by company officials as aggressive. It has been less than six months since the original announcement of the acquisition of The Sera Labs, so we would submit that aggressive is an appropriate characterization.  Speaking of which, CURE has released another PR update this morning, announcing a partnership with a blockbuster movie star which we will share below.

Fresh CURR News:

LOS ANGELES & OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holdings (OTCMKTS: CURR) wholly owned subsidiary, The Sera Labs, Inc., has enlisted Oscar, Golden Globe and Emmy Award-winning Nicole Kidman as the brand’s first-ever strategic business partner and global brand ambassador for their topical products. In addition to being the face of the brand, Kidman will play an integral role in the strategic direction of product development and messaging.

“The partnership with SeraLabs was an easy decision for me,” states Kidman, SeraLabs Strategic Partner and Global Brand Ambassador. “With my injury last year, I experienced the benefit of CBD wellness products firsthand. I believe these products are a vital solution in health and wellness and Nancy and SeraLabs are a company I believe in. Joining them in this partnership is something I am very excited about!” (>>View Full PR)

CURR Video Chart: 

We would suggest our readers take a moment to view the video presentation we’ve prepared for the current CURR chart, which has recently broken through the key resistance areas we highlighted in our previous report.


CURR Video Chart

For All Investor Inquiries on CURR,Contact:
Gary Zwetchkenbaum, Plum Tree Consulting LLC
Email: gzplumtree@gmail.com
Phone: (516) 455-7662
Web: plumtreeconsultingllc.com 

Fresh Options Ideas:

We’ve also identified a couple of solid looking potential plays on the big board earnings calendar this morning:

SMAR 12/18 $70-75 Calls
SFIX Weekly $45-50 Calls

Blue Horseshoe Stocks: AMD, TJX & More

Social Detention, Inc. SODE

Our first order of business this morning is to return to SODE, a stock we recently published a special report on a little under two weeks ago. Immediately following that, we would observe a low of .10 in the stock, which has given way to a very respectable move since then.

Yesterday in a surge of price action and volume, SODE achieved a new high of .153, marking a 53% move in just a shade over a week. We’re going to want to maintain our watch over this play and look for it to establish higher highs and higher lows, continuing this current uptrend.

The TJX Companies, Inc. TJX – Recap

Yesterday in the premarket we reported some excellent progress with the TJX options ideas we presented in our report from May 22nd, the TJX 06/15 $85-90 Calls.

Based on the big move the stock itself made thereafter during yesterday’s session, we have to revisit our ideas again to provide the impressive new highs that were attained, along with our total possible gains so far.

$85 Calls – Range: 2.14-7.86 – Max Gain: 267%
$87.50 Calls – Range: .90-5.56 – Max Gain: 517%
$90 Calls – Range: .35-3.14 – Max Gain: 797%

Advanced Micro Devices, Inc. AMD 

Speaking of solid calls, we made one on AMD, tagging the stock for observation in our report from April 26th.  The move it has made since then is awe-inspiring- after having traded for as little as 10.61 on that day, the stock hasn’t looked back during what has been a month-long bullish surge.

Yesterday, AMD reached a new 52-week high of 14.98, which registers as a highly respectable increase of 41% in just under five weeks.

The stock has been in blue sky breakout mode for the past two sessions now, so it’s going to be very interesting to see where its path takes it from here. There may even be a dip and rip opportunity at some point as profit takers enter the mix, so we’ll want to stay light on our feet.

Extended Watchlist:
CODX, SMAR, GIII, MYL, PLX, NAV